/ 200 Shares
07-Nov-2024 - 11-Nov-2024
₹ 70 - ₹ 74
₹ 14800.00
200
298,996,139
Face Value - ₹ 10/- Per Share
Listing at NSE BSE
157,142 Application Required in Retail for 1 Time.
Registrar : KFin Technologies Limited
Fresh Issue of Equity Shares aggregating upto Rs. 800 Cr and Offer for Sale of Equity Shares aggregating upto Rs. 1,400 Cr
Category | % | Shares/Amount |
---|---|---|
QIB | 75% | 222,972,974 Shares RS.1650.00 CR |
HNI 1 | 5% | 14,864,865 Shares RS.110.00 CR @ 5309 FORM 1X |
HNI 2 | 10% | 29,729,729 Shares RS.220.00 CR @ 10618 FORM 1X |
Retail | 10% | 29,729,729 Shares RS.220.00 CR @ 148649 FORM 1X |
BRLMs: Axis Capital, ICICI Securities, Morgan Stanley, Kotak Mahindra Capital, HDFC Bank, Motilal Oswal
Retail (Upto 2 Lakh) | HNI (2 Lakh to 10 Lakh) | HNI (Above 10 Lakh) |
---|---|---|
148649 FORM 1X | 5309 FORM 1X | 10618 FORM 1X |
Category | Lots | Shares | Amount |
---|---|---|---|
Retail (Upto 2 Lakh) | 1 | 200 | ₹ 14,800 |
Retail (Upto 2 Lakh) | 13 | 2600 | ₹ 192,400 |
S-HNI (2 Lakh to 10 Lakh) | 14 | 2800 | ₹ 207,200 |
S-HNI (2 Lakh to 10 Lakh) | 67 | 13400 | ₹ 991,600 |
B-HNI (Above 10 Lakh) | 68 | 13600 | ₹ 1,006,400 |
11-Nov-2024 16:57
Category | Book Size | Subscription | No. of Times |
---|---|---|---|
QIB | 89,189,190 ₹ 660.00 Cr. | 193,848,200 ₹ 1434.48 Cr. | 2.17x |
HNI (<10 LAKH) | 14,864,865 ₹ 110.00 Cr. | 10,992,600 ₹ 81.35 Cr. | 0.74x |
HNI2 (>10 LAKH) | 29,729,729 ₹ 220.00 Cr. | 20,818,400 ₹ 154.06 Cr. | 0.70x |
RETAIL | 31,428,571 ₹ 232.57 Cr. | 85,441,600 ₹ 632.27 Cr. | 2.72x |
Total | 165,212,355 | 311,100,800 | 1.88x |
Category | Book Size | Subscription | No. of Times |
---|---|---|---|
QIB | 89,189,190 ₹ 660.00 Cr. | 193,848,200 ₹ 1434.48 Cr. | 2.17x |
HNI (<10 LAKH) | 14,864,865 ₹ 110.00 Cr. | 10,992,600 ₹ 81.35 Cr. | 0.74x |
HNI2 (>10 LAKH) | 29,729,729 ₹ 220.00 Cr. | 20,818,400 ₹ 154.06 Cr. | 0.70x |
RETAIL | 31,428,571 ₹ 232.57 Cr. | 85,441,600 ₹ 632.27 Cr. | 2.72x |
Total | 165,212,355 | 311,100,800 | 1.88x |
*Excluding Anchor
Total No. of Application Approx : ~388414 (2.47 Appwise)
Disclaimer: The above-mentioned information / data are sourced from the websites of National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) and are subject to change on real time basis. For updated information / data you can visit their respective website. The information / data provided herein above are for information purpose only and provided "AS IS" and "AS AVAILABLE" basis and without warranty, express or implied. We do not guarantee or warrant the accuracy, adequacy or completeness of the information received through the said websites. “We” hold not responsibility of any kind as regard to any discrepancies, errors, omissions, losses or damages. “We” including its affiliates and any of its officers, directors, personnel and employees, shall not liable for any loss, damage of any nature, including but not limited to direct, indirect, punitive, special, exemplary, consequential, as also any loss of profit in any way arising from the use of information / data received through the said websites. The recipient alone shall be fully responsible / are liable for any decision taken on the basis of such information / data. All recipients should before acting upon the said information make their own investigation, seek appropriate professional advice.
Niva Bupa Health Insurance Company Limited (“Niva Bupa”) was incorporated on September 5, 2008. Niva Bupa is one of India’s largest and fastest growing Standalone Health Insurers (“SAHI”) based on overall health GDPI of ?5,494.43 crore in Fiscal 2024. From Fiscal 2022 to Fiscal 2024, their overall Gross Written Premium (“GWP”) grew at a CAGR of 41.27% and their GWP from retail health grew at a CAGR of 33.41%.
From the 3 months ended June 30, 2023 to the 3 months ended June 30, 2024, the overall GWP also grew by 30.84% and the GWP from retail health grew by 31.99%.
Their growth in overall health Gross Direct Premium Income (“GDPI”) from Fiscal 2022 to Fiscal 2024 of 41.37% is one of the highest growths among SAHIs, and is almost double of the industry’s average, which is increased by 21.42% from Fiscal 2022 to Fiscal 2024.
Niva Bupa had a market share in the Indian SAHI market of 17.29%, 16.24%, 15.58% and 13.87% for year-to-date August 2024 (Fiscal 2025), Fiscals 2024, 2023, and 2022 respectively based on retail health GDPI.
Company’s products are broadly categorized into (a) retail products, which are intended for individuals and families and (b) group products. The retail and group products can be classified into Health Insurance, Personal Accident and Travel Insurance.
Through their diverse and evolving product suite and their ‘Niva Bupa Health’ mobile application and website, they aim to provide their customers access to a range of healthcare and disease management solutions.
Bupa offers health insurance, healthcare provision and aged services, and it has businesses around the world but, principally, in the UK, Australia, Spain, Chile, Poland, New Zealand, Hong Kong SAR, Türkiye, Brazil, Mexico, India, the US, Middle East and Ireland. Bupa also has an associate business in Saudi Arabia.
With Bupa Singapore Holdings Pte. Ltd. and Bupa Investments Overseas Ltd as company promoters, they are the only health insurance company in India majority controlled by a foreign global healthcare group.
Niva Bupa had 1.50 crore active lives insured as of June 30, 2024. They are strategically focused on the retail health market and their GWP from their retail health products was 67.65% and 68.47% of their overall GWP for the 3 months ended June 30, 2024, and Fiscal 2024, respectively.
Niva Bupa has a diversified channel mix with corporate agents (banks and others), individual agents and broker channels contributing 27.25%, 32.07% and 27.04% respectively of their business by GDPI for Fiscal 2024 respectively.
Competitive Strength
Granular retail health insurer with a focus on delivering robust GWP growth, capital efficiency and profitability;
Diverse product suite for customers, bolstered by the track record for product innovation;
Access to “360-degree” health and wellness ecosystem platform provides a holistic health proposition for customers;
Bupa parentage and brand associated with health insurance and healthcare;
Domain knowledge and experience in claims and provider management;
Multi-channel diversified pan-India distribution, with technology-led empowerment of distribution partners;
Technology and analytics platforms;
Experienced management team backed by established investors and underpinned by sustainable employment practices.
Business Strategies
Continuing to grow the product portfolio to serve the needs of customers, expand the partnerships with Network Hospitals, and further develop the healthcare ecosystem;
Deepen culture of sustainability and “doing the right thing” to create a sustainable health franchise for future generations.
Niva Bupa Health Insurance Company Limited's revenue increased by 44.05% and profit after tax (PAT) rose by 552.73% between the financial year ending with March 31, 2024 and March 31, 2023.
Period Ended | 30 Jun 2024 | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 |
Assets | 6,542.06 | 6,191.87 | 3,876.57 | 2,738.44 |
Revenue | 1,124.90 | 4,118.63 | 2,859.24 | 1,884.54 |
Profit After Tax | -18.82 | 81.85 | 12.54 | -196.53 |
Net Worth | 2,031.77 | 2,049.59 | 831.12 | 507.65 |
Reserves and Surplus | 1,282.44 | 1,282.02 | 334.26 | 125.40 |
Total Borrowing | 250.00 | 250.00 | 250.00 | 250.00 |
Amount in ? Crore |
The company proposes to utilise the Net Proceeds towards the following objects:
Once you create your account, Login to Us.
Under IPO Section, you will be able to see a list of Ongoing IPOs, where you can click on apply button.
Add quantity of shares to apply – Maximum 3 bids are allowed (For retail category – max amount Rs.2,00,000/-).
Enter your UPI ID and you will receive mandate on your UPI App.
Once you accept the mandate, Application is submitted successful.